The CARDIO-TTRansform Study

is a Phase 3 clinical trial of an investigational medication called AKCEA-TTR-LRx for people living with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM).

Find out if CARDIO-TTRansform is right for you.

Get Started

The Study

ico/24/play Created with Sketch.

Learn about how the CARDIO-TTRansform trial works.

Find a Study Site

ico/24/play Created with Sketch.

Enter your location to see all study sites near you.

About ATTR-CM

ico/24/play Created with Sketch.

Read about ATTR-CM and current treatment options.